RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Birmingham, AL · +73 more sites
Type 2 Diabetes clinical trials in Birmingham, AL
16 recruiting type 2 diabetes studies with a site in Birmingham, AL.
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Anniston, AL · Birmingham, AL · +41 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Birmingham, AL · Dothan, AL · +54 more sites
RecruitingPhase 2NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Birmingham, AL · +24 more sites
RecruitingNot applicableNCT07032844
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingNot applicableNCT06906627
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Sponsor: Duke University
Birmingham, AL · +6 more sites
RecruitingPhase 3NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Birmingham, AL · +14 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Birmingham, AL · Pelham, AL · +97 more sites
RecruitingPhase 3NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Sponsor: Eli Lilly and Company
Birmingham, AL · +58 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Birmingham, AL · Huntsville, AL · +82 more sites
RecruitingPhase 2NCT07340320
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Sponsor: Corxel Pharmaceuticals
Birmingham, AL · Huntsville, AL · +31 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Birmingham, AL · +63 more sites
RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Birmingham, AL · Daphne, AL · +25 more sites
RecruitingNot applicableNCT06628453
CGM for Management of Type 2 Diabetes in Pregnancy
Sponsor: University of Alabama at Birmingham
Birmingham, AL · +6 more sites
RecruitingPhase 2NCT07502508
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Sponsor: Biomea Fusion Inc.
Birmingham, AL · +16 more sites
RecruitingNot applicableNCT07220213
FELLAShip to Better Health
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.